30/OCT/14
The European Patent Office grants Neuron Bio with a patent for the use of simvastatin as an antiepileptic drug
Neuron Bio has been granted with the European patent for the use of simvastatin in the treatment and prevention of epilepsy and its related seizures.
This is the first patent granted to Neuron Bio by the European Patent Office and it might enable the company to reach marketing agreements with third partiess for the use of simvastatin as an antiepileptic drug in Europe. The simvastatin is a known drug, commonly used to treat high cholesterol, something that might allow carrying out directly clinical assays in phase II (clinical proof of concept in humans) for the new patented indication.
|